Mirati Therapeutics, Inc.

Schonfeld Strategic Advisors LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

1,161

Value ($000)

68

Weight

0.0%

2019 Q4 - 2023 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	68	0.0%	1,161	12/31/2023
2023 Q3	11/14/2023	1,337	0.0%	30,700	9/30/2023
2023 Q2	8/14/2023	4,684	0.0%	129,636	6/30/2023
2023 Q1	5/15/2023	848	0.0%	22,799	3/31/2023
2022 Q4	2/14/2023	372	0.0%	8,200	12/31/2022
2022 Q3	11/14/2022	1,636	0.0%	23,427	9/30/2022
2022 Q2	8/15/2022	2,149	0.0%	32,001	6/30/2022
2021 Q4	2/14/2022	2,398	0.0%	16,350	12/31/2021
2021 Q3	11/16/2021	3,313	0.0%	18,727	9/30/2021
2021 Q2	11/16/2021	4,866	0.1%	30,122	6/30/2021
2020 Q4	2/16/2021	373	0.0%	1,692	12/31/2020
2020 Q3	11/19/2020	297	0.0%	1,786	9/30/2020
2020 Q2	8/14/2020	637	0.0%	5,579	6/30/2020
2020 Q1	5/15/2020	1,280	0.1%	16,655	3/31/2020
2019 Q4	2/14/2020	3,627	0.1%	28,137	12/31/2019